For decades, high cholesterol has meant a lifetime of daily pills, repeat blood tests and constant reminders that the biggest ...

An investigational drug called lerodalcibep lowered low-density lipoprotein (LDL) cholesterol, or “bad” cholesterol, by 50% or more, a new study showed. The year-long clinical trial included people ...

A new Merck pill called enlicitide slashes levels of harmful LDL cholesterol by up to 60%, similar to injectable PCSK9 drugs already on the market. File Photo by John Angelillo/UPI The drug, called ...

(Ivanhoe Newswire) According to a recent study, patients unable to control their cholesterol levels with medications may someday be able to lower bad cholesterol with a shot. In its first preliminary ...

Imagine a future where high cholesterol, a primary driver of heart disease, could be treated with a single injection rather than a lifetime of daily pills. That future may be closer than we think, ...

Merck & Co. Inc. (NYSE:MRK) on Tuesday shared topline results from the Phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate for hypercholesterolemia on a moderate ...